SPARTA Biodiscovery, a company that develops novel methods to analyse nanoparticles for advanced medicines, has received a £3.5 million seed investment from Sartorius, a leading provider of laboratory and bioprocessing solutions.
The investment will help SPARTA deploy its system in various commercial settings and accelerate its product launch. SPARTA was founded by Imperial researchers and is based at the White City Incubator.